Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| capsule, delayed release | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| r2 pharma, llc | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ESOMEPRAZOLE STRONTIUM | esomeprazole strontium | capsule, delayed release, oral | 70849-200NDA |
| ESOMEPRAZOLE STRONTIUM | esomeprazole strontium | capsule, delayed release, oral | 70849-400NDA |
Enquiry
Common questions
- Is R2 Pharma, LLC FDA approved?
- R2 Pharma, LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does R2 Pharma, LLC make?
- 2 products are listed under R2 Pharma, LLC in the openFDA NDC Directory, most often as capsule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.